STAGE IV LIVER CANCER
Clinical trials for STAGE IV LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV LIVER CANCER trials appear
Sign up with your email to follow new studies for STAGE IV LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug attack shows promise against tough liver cancer
Disease control OngoingThis study tests whether adding two targeted drugs (atezolizumab and bevacizumab) to standard chemotherapy helps people with a rare, advanced liver cancer live longer without their disease getting worse. About 88 adults with cancer that cannot be surgically removed will be random…
Matched conditions: STAGE IV LIVER CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New drug hopes to boost Radiation's punch against tough gut cancers
Symptom relief OngoingThis early-phase study tests an oral drug called ropidoxuridine (IPdR) in people with advanced gastrointestinal cancers that cannot be cured. The goal is to find the safest dose and see if it can make radiation therapy more effective at shrinking tumors. Nineteen participants wit…
Matched conditions: STAGE IV LIVER CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Jun 10, 2026 13:24 UTC
-
One-Day liver cancer treatment shows promise in early trial
Symptom relief OngoingThis early-phase study tests whether a liver cancer treatment called Y90 radioembolization can be safely done in a single session instead of the usual two-day process. The treatment uses tiny radioactive beads injected into the liver's blood supply to block tumor growth. Research…
Matched conditions: STAGE IV LIVER CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 29, 2026 14:16 UTC